Triple negative breast cancer (TNBC), characterized by a lack of expression of estrogen (ER) and progesterone (PR) receptors and a lack of human epidermal growth factor receptor 2 (HER2) amplification, is the most aggressive breast cancer subtype with the least favorable outcomes. Here, ERBB2 is linked to breast cancer.